Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer

NCT00593008 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Temsirolimus
DRUG: Gemcitabine

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]